335 related articles for article (PubMed ID: 10391608)
1. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
Kanbak M
Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
[TBL] [Abstract][Full Text] [Related]
2. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
[TBL] [Abstract][Full Text] [Related]
3. Monitoring and management of anticoagulation in children requiring extracorporeal circulation.
Malviya S
Semin Thromb Hemost; 1997; 23(6):563-7. PubMed ID: 9469631
[TBL] [Abstract][Full Text] [Related]
4. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
Despotis GJ; Joist JH
J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
[TBL] [Abstract][Full Text] [Related]
7. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
Kanbak M; Oc B; Salman MA; Ocal T; Oc M
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
[TBL] [Abstract][Full Text] [Related]
8. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.
Muedra V; Bonanad S; Gómez M; Villalonga V; Sánchez F; Llopis JE
Perfusion; 2011 Nov; 26(6):487-95. PubMed ID: 21665912
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
Brister SJ; Ofosu FA; Buchanan MR
Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
[TBL] [Abstract][Full Text] [Related]
11. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
12. [Heparin resistance associated with elevated factor VIII].
Kumano N; Ikeda S; Arimori Y; Ono T; Saeki S
Masui; 2008 Apr; 57(4):471-3. PubMed ID: 18416208
[TBL] [Abstract][Full Text] [Related]
13. Safety issues in heparin and protamine administration for extracorporeal circulation.
Jobes DR
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
[TBL] [Abstract][Full Text] [Related]
14. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
15. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
16. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
[TBL] [Abstract][Full Text] [Related]
17. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
[TBL] [Abstract][Full Text] [Related]
18. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
19. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
Teoh KH; Young E; Bradley CA; Hirsh J
Circulation; 1993 Nov; 88(5 Pt 2):II420-5. PubMed ID: 8222188
[TBL] [Abstract][Full Text] [Related]
20. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
